Aconite and glycyrrhiza composition transdermal patch
A technology of licorice composition and transdermal patch, which is applied in the field of medicine, can solve the problems of being unsuitable for patients who have difficulties in taking it orally, affecting the normal life of patients, and consuming time and effort to prepare it, so as to reduce cardiotoxicity and other adverse reactions, Avoid the first-pass effect and improve the effect of specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1~ Embodiment 3
[0047] Embodiment 1~Example 3 Adhesive type screening
[0048] According to the bioavailability ratio of common external preparations and oral preparations 1.2 conversion, the above-mentioned administration area (6.5×10cm 2 ), the content of active ingredient extract of aconite and active ingredient extract of licorice in the prepared patch should be greater than 5wt%, so the maximum drug-loading concentration of the active ingredient extract of aconite and active ingredient extract of licorice in the adhesive matrix should be greater than 5wt%. .
[0049] According to the above patch preparation method, the aconite extract and licorice extract were added to different adhesives to directly prepare sample patches with different drug contents (contents were 1wt%, 2.5wt%, 5wt%, 10wt%, 15wt%, 20wt%) %), observe the prescription compatibility of the patch with the naked eye and a microscope (if the drug content exceeds the maximum drug loading capacity of the adhesive matrix, ther...
Embodiment 4~ Embodiment 12
[0059] Embodiment 4~Example 12 transdermal absorption enhancer type screening
[0060] Using Duro-Tak87-9301 as adhesive, add the following penetration enhancers: propylene glycol (PG), oleic acid (OA), isopropyl myristate (IPM), azone (Azone), N-methylpyrrolidone (NMP ), diethylene glycol monoethyl ether (Transcutol P), menthol (MT), menthol heptyl ester (M-OCT), menthol decyl ester (M-DOD), made into 9 transdermal patches ( Examples 4 to 12), the components of the patch and their contents are shown in Table 2; the transdermal permeation performance of each patch was investigated by in vitro percutaneous penetration test, two kinds of aconitine and licorice isoflavane A The time-drug cumulative permeation curve of the active ingredient is as follows: image 3 with Figure 4 shown. Depend on image 3 , Figure 4 It can be seen that the patch with NMP as the transdermal absorption enhancer has the best skin permeability (p<0.01), therefore, NMP is preferred as the transder...
Embodiment 13~ Embodiment 15
[0061] Embodiment 13~Example 15 Transdermal absorption accelerator NMP content optimization
[0062] Using NMP as a transdermal absorption accelerator, three kinds of transdermal patches (Example 13-Example 15) with different NMP contents were prepared. The components and contents of the drug storage layer of the patch are shown in Table 2; The permeation test was used to investigate the percutaneous penetration performance of each patch (Example 8, Example 13-Example 15). The time-drug cumulative penetration curves of the two active ingredients of aconitine and licorice isoflavane A are as follows: Figure 5 with Image 6 shown. Depend on Figure 5 , Image 6 It can be seen that when the content of NMP reaches 5wt%, its permeability-enhancing activity is close to saturation, therefore, the preferred concentration of NMP is 5wt%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com